Oxford vaccine data could go before regulators this year, says top scientist

The Oxford vaccine showed early promise in the first human trial
when it produced an immune response, underlining its position as
one of the leading candidates in the race to produce a vaccine
against a disease that has crippled the global economy.
(File photo: Sean Elias/Handout via REUTERS)

An experimental Covid-19 vaccine being developed by the University of Oxford and AstraZeneca could be put before regulators this year if scientists are able to gather enough data, the director of the Oxford Vaccine Group said on Tuesday (25).

“It is just possible that if the cases accrue rapidly in the clinical trials, that we could have that data before regulators this year, and then there would be a process that they go through in order to make a full assessment of the data,” Andrew Pollard told BBC Radio.

The Oxford vaccine showed early promise in the first human trial when it produced an immune response, underlining its position as one of the leading candidates in the race to produce a vaccine against a disease that has crippled the global economy.

Full story at Eastern Eye.